by Desiree Cobb-Olori | Feb 6, 2025
NF-L is a validated biomarker for assessing disease progression, intensity, and treatment response across a wide range of neurodegenerative disorders including Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), amyotrophic lateral sclerosis...
by Kelly Morris | Oct 15, 2024
Herman B. Fernandes, Jose Beltran, Mei Kwan, John Shea, Daniel Havas, Afshin Ghavami, Taleen Hanania Amyotrophic lateral sclerosis (ALS) is a neurodegenerative motor neuron disease characterized by specific cell death of the upper and/or lower motor neurons. The...
by Kelly Morris | Oct 15, 2024
Alexis Zajicek 1, Brian Haner 1, Melville Osborne 1, Moriah Jacobson2, Michael Carr2, Taleen Hanania1 Affiliation Details:1 Psychogenics Inc, Paramus NJ, USA2 Taconic Biosciences, Inc., Rensselaer, NY Amyotrophic lateral sclerosis (ALS) is a fatal neurological...
by susan.forootan | May 20, 2024
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive loss of upper and lower motor neurons producing muscle denervation, motor impairments, and brain atrophy. Deposition of insoluble cytosolic inclusions of Transactive...
